Lung Cancer Clinical Trial

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Summary

To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.

View Full Description

Full Description

We will conduct a 4-arm randomized trial comparing 4 interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among smokers in underserved demographic groups. The 3,200 participants to be enrolled will be current smokers who are Black, Hispanic, and/or have low socioeconomic status (defined as household income <200% of the federal poverty line or a high school education or less) or rural residence who are referred for low-dose computed tomography (LDCT) screening at 4 large health systems. All adult patients with LDCT orders will be further screened for eligibility. Eligible patients will enroll with opt-out consent and complete the study using the NIH-funded Way to Health online research portal. The primary outcome will be biochemically confirmed, sustained abstinence from smoking tobacco for 6 months following participants' selected quit dates. Relapse rates will be tracked at 12 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Current smoker (≥ 1 cigarettes per day, not including e-cigarettes)
Has a low-dose computed tomography (LDCT) scan ordered by their physician
Underserved, defined as one or more of the following: (a) Black, (b) Hispanic, (c) rural residence, or (d) low socioeconomic status (Defined as one or both of: high-school education or less, or household income <200% of the federal poverty line)
Able to receive study invitation and screening, by virtue of showing up to a radiology location affiliated with a participating health system for the LDCT, or having a valid email address or telephone number on file with the health system
Access to a cell phone with text messaging or the internet
Aged 18 years or older

Exclusion Criteria:

No cell phone

Study is for people with:

Lung Cancer

Estimated Enrollment:

3200

Study ID:

NCT04798664

Recruitment Status:

Recruiting

Sponsor:

University of Pennsylvania

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Kaiser Permanente Southern California
Oakland California, 94612, United States More Info
Michael Gould, MD MS
Contact
Michael Gould, MD MS
Principal Investigator
Mohamed Ismail, MD MPH
Sub-Investigator
Henry Ford Health System
Detroit Michigan, 48202, United States More Info
Christine Neslund-Dudas, PhD
Contact
Christine Neslund-Dudas, PhD
Principal Investigator
Michael Simoff, MD
Sub-Investigator
Geisinger
Danville Pennsylvania, 17822, United States More Info
Matthew Facktor, MD
Contact
Matthew Facktor, MD
Principal Investigator
Charlotte Collins, PhD
Sub-Investigator
University of Pennsylvania
Philadelphia Pennsylvania, 19104, United States More Info
Scott D Halpern, MD PhD
Contact
Scott Halpern, MD PhD
Principal Investigator
Anil Vachani, MD MS
Sub-Investigator
Joanna Hart, MD MS
Sub-Investigator
Kevin Volpp, MD PhD
Sub-Investigator
Rachel Kohn, MD MS
Sub-Investigator
Dylan Small, PhD
Sub-Investigator
Alisa Stephens-Shields, PhD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

3200

Study ID:

NCT04798664

Recruitment Status:

Recruiting

Sponsor:


University of Pennsylvania

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.